Hydrogel embedding of precision‐cut liver slices in a microfluidic device improves drug metabolic activity
- 18 January 2011
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 108 (6) , 1404-1412
Abstract
A microfluidic‐based biochip made of poly‐(dimethylsiloxane) was recently reported for the first time by us for the incubation of precision‐cut liver slices (PCLS). In this system, PCLS are continuously exposed to flow, to keep the incubation environment stable over time. Slice behavior in the biochip was compared with that of slices incubated in well plates, and verified for 24 h. The goal of the present study was to extend this incubation time. The viability and metabolic activity of precision‐cut rat liver slices cultured in our novel microflow system was examined for 72 h. Slices were incubated for 1, 24, 48, and 72 h, and tested for viability (enzyme leakage (lactate dehydrogenase)) and metabolic activity (7‐hydroxycoumarin (phase II) and 7‐ethoxycoumarin (phase I and II)). Results show that liver slices retained a higher viability in the biochip when embedded in a hydrogel (Matrigel) over 72 h. This embedding prevented the slices from attaching to the upper polycarbonate surface in the microchamber, which occurred during prolonged (>24 h) incubation in the absence of hydrogel. Phase II metabolism was completely retained in hydrogel‐embedded slices when medium supplemented with dexamethasone, insulin, and calf serum was used. However, phase I metabolism was significantly decreased with respect to the initial values in gel‐embedded slices with medium supplements. Slices were still able to produce phase I metabolites after 72 h, but at only about ∼10% of the initial value. The same decrease in metabolic rate was observed in slices incubated in well plates, indicating that this decrease is due to the slices and medium rather than the incubation system. In conclusion, the biochip model was significantly improved by embedding slices in Matrigel and using proper medium supplements. This is important for in vitro testing of drug metabolism, drug–drug interactions, and (chronic) toxicity. Biotechnol. Bioeng. 2011; 108:1404–1412.Keywords
This publication has 35 references indexed in Scilit:
- Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studiesNature Protocols, 2010
- Microfluidic biochip for the perifusion of precision‐cut rat liver slices for metabolism and toxicology studiesBiotechnology and Bioengineering, 2009
- Novel Intra-Tissue Perfusion System for Culturing Thick Liver TissueTissue Engineering, 2007
- Gene Expression Profiling of Extracellular Matrix as an Effector of Human Hepatocyte Phenotype in Primary Cell CultureToxicological Sciences, 2007
- Keratinocyte serum-free medium maintains long-term liver gene expression and function in cultured rat hepatocytes by preventing the loss of liver-enriched transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- Role of the Kupffer Cell in Mediating Hepatic Toxicity and CarcinogenesisToxicological Sciences, 2006
- Organ Slice Viability Extended for Pathway Characterization: An in Vitro Model to Investigate FibrosisToxicological Sciences, 2004
- Glucuronidation of 4-methylumbelliferone and 4-hydroxybiphenyl and in vitro induction of UDP-glucuronosyltransferase 2B12-mRNA in precision-cut rat liver slicesExperimental and Toxicologic Pathology, 2003
- Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slicesXenobiotica, 2002
- HISTOLOGICAL AND BIOCHEMICAL EVALUATION OF PRECISION-CUT LIVER SLICESToxicology Mechanisms and Methods, 2001